Heart MRI shows promise as a 'Silver Standard' for diagnosing rare cardiac masses
NCT ID NCT07335770
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This observational study will enroll 2000 people with suspected or confirmed cardiac masses (tumors or blood clots) to see if cardiovascular magnetic resonance (CMR) can accurately tell what the mass is and guide treatment. Participants will get a CMR scan and be followed for 3 years to track survival, recurrence, and complications. The goal is to validate CMR as a reliable non-invasive tool for diagnosis and prognosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cardiovascular magnetic resonance (CMR) scan
What this could lead to
If successful, this could make CMR a reliable, non-invasive tool to diagnose cardiac masses and guide treatment, reducing the need for biopsies.
What could go wrong
This is an observational study, not a treatment trial. It may confirm what is already known, and results may not change current practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC MASSES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.